4
Changes in Ownership
ANAPTYSBIO, INC Filed Acc 0001415889-24-019829
Chief Medical Officer sold 1,500 shares at $35.00 ($52,500)
- Chief Medical Officer acquired 1,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lizzul Paul F. Chief Medical Officer | 2024-07-18 | Option exercise 10b5-1 | +1,500 | $18.50 | $27,750 | 13,118 | D: show line 1 in the form |
| Lizzul Paul F. Chief Medical Officer | 2024-07-18 | Sale 10b5-1 | −1,500 | $35.00 | $52,500 | 11,618 | D: show line 2 in the form |
| Open-market sales · 1,500 sh · avg $35.00 · $52,500 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lizzul Paul F. Chief Medical Officer | 2024-07-18 | Option exercise · Common 10b5-1 | −1,500 | 88,500 | D: show line 3 in the form |
Loading xslF345X05/form4-07202024_120740.xml…